Metoprolol dosage forms
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol Dosage Forms: Sustained Release and Extended Release Tablets
Metoprolol is available in several oral dosage forms designed to control the rate and duration of drug release. The most common forms are sustained release (SR) and extended release (ER) tablets, which are formulated to provide a controlled release of metoprolol over a 24-hour period, allowing for once-daily dosing. These formulations typically use a matrix system or coated pellets to achieve the desired release profile, ensuring consistent blood levels and improved patient compliance バイチワル，アナンド1995Baichwal1995Sun2020.
Modified and Bilayer Tablets for Immediate and Sustained Release
Some metoprolol tablets are designed as bilayer systems, combining an immediate release layer with a sustained release layer. For example, a bilayer tablet may contain 30 mg of metoprolol for immediate release and 70 mg in a sustained release matrix, using polymers such as ethylcellulose and hydroxypropyl methylcellulose to control the release rate. This approach provides both rapid onset and prolonged therapeutic effect .
Mini-Tablets and Multiple-Unit Sustained Release (MUSR) Systems
Innovative dosage forms like extended-release mini-tablets and multiple-unit sustained-release (MUSR) tablets have been developed. Mini-tablets can be optimized for drug release using advanced modeling techniques, and MUSR tablets contain numerous small pellets, each with a core, drug-containing layer, and outer film. These systems offer reliable and consistent drug release, with the MUSR form using a membrane-controlled mechanism to maintain steady drug levels Issa2022Sun2020.
Combination Dosage Forms
Metoprolol is also available in combination dosage forms with other cardiovascular drugs, such as calcium channel blockers or angiotensin-II receptor antagonists. These combination tablets are formulated for once-daily administration and may contain metoprolol in sustained release form alongside other agents, providing comprehensive management of cardiovascular conditions Кодгуле2012Sharma2025.
Orodispersible Films and Individualized Dosing
For patients who have difficulty swallowing tablets, orodispersible films (ODFs) containing metoprolol tartrate have been developed. These films dissolve quickly in the mouth and can be precisely dosed using inkjet printing technology, making them suitable for pediatric or individualized therapy .
Capsules and Computer-Controlled Release
Experimental dosage forms include capsules with computer-controlled release mechanisms. These capsules can release metoprolol rapidly or over several hours, depending on the programmed settings, offering a high degree of flexibility in drug delivery .
Considerations for Crushing Modified-Release Tablets
It is important to note that crushing modified-release metoprolol tablets is not recommended, as it can alter the drug release profile and potentially lead to dose dumping or reduced efficacy. Clinical guidelines advise against this practice, especially for patients with swallowing difficulties .
Conclusion
Metoprolol is available in a variety of oral dosage forms, including sustained release tablets, bilayer tablets, mini-tablets, MUSR systems, combination tablets, orodispersible films, and experimental computer-controlled capsules. These formulations are designed to optimize therapeutic outcomes, improve patient compliance, and accommodate special patient needs. Care should be taken to use these dosage forms as intended to ensure safe and effective therapy.
Sources and full results
Most relevant research papers on this topic
Static and dynamic structural features of single pellets determine the release behaviors of metoprolol succinate sustained-release tablets.
The study provides insight into the intrinsic quality of metoprolol succinate sustained-release tablets and guidance for reverse engineering multiple-unit sustained-release dosage forms.
DOI
Formulation of Metoprolol Bilayer Tablets as an Oral Modified Release Dosage Form
Metoprolol bilayer tablets with a 2:1 ratio of ethylcellulose to HPMC in the sustained release layer provide a better release profile and tablet integrity compared to conventional metoprolol tartrate tablets.
Methods for the treatment of cardiovascular disorders
A pharmaceutical dosage form for treating cardiovascular disorders, suitable for once daily administration, combines metoprolol in sustained release form with calcium channel blockers and release rate controlling auxiliary veschestvami.
Fundamental Investigations into Metoprolol Tartrate Deposition on Orodispersible Films by Inkjet Printing for Individualised Drug Dosing
Inkjet printing can produce uniform metoprolol tartrate doses on orodispersible films for pediatric use, but nozzle aging may impact the final dose.
EVALUATION OF IN VITRO DISSOLUTION PROFILES OF MODIFIED-RELEASE METOPROLOL SUCCINATE TABLETS CRUSHED USING MORTAR AND PESTLE TECHNIQUE.
Crushing modified-release metoprolol succinate tablets using a mortar and pestle technique may cause in vitro effects similar to those observed in clinical practice, potentially affecting patient safety.
DOI